Sulfhydryl Compounds
- Name
- Sulfhydryl Compounds
- Accession Number
- DBCAT000316
- Description
Compounds containing the -SH radical.
- Drugs
Drug Drug Description Azathioprine An immunosuppressant used to prevent renal transplant rejection, treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis. Mercaptopurine An antineoplastic agent used to treat acute lymphocytic leukemia. Acetylcysteine A medication that can be used as a mucolytic in patients with certain lung conditions and as an antidote for acetaminophen overdose. Dimercaprol A chelating agent used as an antidote to arsenic, gold, and mercury poisoning, as well as acute lead poisoning in combination with edetate calcium disodium. Coenzyme M A uroprotective agent used for the reduction and prophylaxis of oxazaphosphorine-induced toxicity in the urinary tract. Carbocisteine A expectorant mucolytic used in the relief of respiratory of COPD and other conditions associated with increased mucus viscosity. Cysteine An amino acid commonly found as a component of total parenteral nutrition and used as an antidote for acetaminophen overdose. Succimer A mercaptodicarboxylic acid heavy metal chelator used in the treatment of heavy metal poisoning. Mercaptoethanol Not Available Dimercaptosuccinic acid Not Annotated Cysteamine A cystine depleting agent used to treat the effects of cystinosis. S-Methylcysteine Not Available Cysteine-S-acetamide Not Available S-Phosphocysteine Not Available D-pantetheine 4'-phosphate Not Available Butyrylthiocholine A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity. [PubChem] S-sulphocysteine Not Available S-Benzylcysteine Not Available Erdosteine A mucolytic agent used to treat conditions characterized by pathological mucus such as respiratory tract infections and chronic obstructive pulmonary disease (COPD). Alethine Investigated for use/treatment in blood (blood forming organ disorders, unspecified), lymphoma (unspecified), and multiple myeloma. Sodium aurothiomalate A disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis. Technetium Tc-99m succimer A radioactive diagnostic agent used as an aid in the scintigraphic evaluation of renal parenchymal disorders. Pantethine A naturally occurring compound derived from panthothenic acid. It acts as an intermediate in endogenous coenzyme A synthesis and is used as a dietary supplement to treat hypertriglyceridemia. Lesinurad A uric acid 1 transporter inhibitor typically used in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout in patients with inadequate control of uric acid levels with xanthine oxidase inhibitor monotherapy. Bucillamine Bucillamine has been used in trials studying the treatment and prevention of Gout and Rheumatoid Arthritis. Thioglycolic acid Thioglycolic acid is under investigation in clinical trial NCT03238105 (Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light). 2,3-Dimercapto-1-propanesulfonic acid Not Annotated Ergothioneine Not Annotated Phosphocysteamine Not Annotated S-Nitrosoglutathione Not Annotated Pravibismane Not Annotated - Drugs & Drug Targets